Literature DB >> 11206957

Consensus document for transfusion-related iron overload.

E Vichinsky1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11206957     DOI： 10.1016/s0037-1963(01)90054-x

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  5 in total

Review 1.  Ferritins: iron/oxygen biominerals in protein nanocages.

Authors:  Elizabeth C Theil; Manolis Matzapetakis; Xiaofeng Liu
Journal:  J Biol Inorg Chem       Date:  2006-07-26       Impact factor: 3.358

2.  Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease.

Authors:  Payal C Desai; Allison M Deal; Emily R Pfaff; Bahjat Qaqish; Leyna M Hebden; Yara A Park; Kenneth I Ataga
Journal:  Am J Hematol       Date:  2015-05-28       Impact factor: 10.047

3.  Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.

Authors:  Ellen B Fung; Paul R Harmatz; Meredith Milet; Vinod Balasa; Samir K Ballas; James F Casella; Lee Hilliard; Abdullah Kutlar; Kenneth L McClain; Nancy F Olivieri; John B Porter; Elliott P Vichinsky
Journal:  Transfusion       Date:  2008-05-29       Impact factor: 3.157

4.  Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease.

Authors:  Elliott Vichinsky; Françoise Bernaudin; Gian Luca Forni; Renee Gardner; Kathryn Hassell; Matthew M Heeney; Baba Inusa; Abdullah Kutlar; Peter Lane; Liesl Mathias; John Porter; Cameron Tebbi; Felicia Wilson; Louis Griffel; Wei Deng; Vanessa Giannone; Thomas Coates
Journal:  Br J Haematol       Date:  2011-05-19       Impact factor: 6.998

Review 5.  Sickle cell anaemia: progress in pathogenesis and treatment.

Authors:  Samir K Ballas
Journal:  Drugs       Date:  2002       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.